ALS is not one disease, it's a forest of causes, waiting to be understood
The ALS Challenge
Amyotrophic Lateral Sclerosis (ALS) is the 3rd most common neurodegenerative disease in the world
120,000
new cases each year
2-4
years average survival
12-16
months diagnostic delay
+50,000€
annual healthcare cost (1 patient)
Our Solution
SynBio-based biosensor as a diagnostic test
🩺
Early diagnosis
Accessible, fast, low cost
🏆
World First
We are the 1st project to detect ALS at the molecular level
⚡
Before Symptoms
Before the main symptoms appear and even before neuronal degeneration begins